Vivus weight loss drug faces safety questions

Tuesday, July 13, 2010 - 07:14 in Health & Medicine

By 2010-07-13T12:00:23Z NEW YORK (AP) -- Vivus Inc.'s potential weight loss drug Qnexa will likely draw scrutiny over nervous system and psychiatric side effects from a panel of Food and Drug Administration experts this week....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net